Results 141 to 150 of about 2,503,880 (309)

Tracking CDK1 Dynamics With a Novel Biosensor Mouse and Clinical Cohorts to Predict CDK4/6 Inhibitor Sensitivity in ER+ Breast Cancer

open access: yesAdvanced Science, EarlyView.
Cyclin‐dependent kinase (CDK) 1 activity is a dynamic marker of treatment response in estrogen receptor positive breast cancer. Patient cohorts reveal CDK1 activity increases during progression to invasive disease, where high expression correlates with poor survival. Using a novel Cdk1 biosensor mouse alongside in vitro models, we demonstrate that CDK1
Sarah Alexandrou   +17 more
wiley   +1 more source

New exploration of KRASG12D inhibitors and the mechanisms of resistance

open access: yesExperimental Hematology & Oncology
The development of Kirsten rat sarcoma viral oncogene homologue (KRAS) targeted therapies has been the focus of cancer treatment. The most common mutant subtypes of KRAS driver genes are G12C, G12V, and G12D, and are associated with poor prognosis. Up to
Ying Li, Junfeng Zhao, Yintao Li
doaj   +1 more source

PROTACs in Colorectal Cancer: A New Era in Targeted Protein Degradation Therapy

open access: yesAdvances in Clinical Pharmacology and Therapeutics
Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide, with treatment challenges arising from late-stage diagnosis, therapy resistance, and the presence of undruggable targets.
Farzad Sadri
doaj   +1 more source

Hepatitis B viral core protein disrupts human host gene expression by binding to promoter regions

open access: yesBMC Genomics, 2012
Background The core protein (HBc) of hepatitis B virus (HBV) has been implicated in the malignant transformation of chronically-infected hepatocytes and displays pleiotropic functions, including RNA- and DNA-binding activities.
Guo Yanhai   +8 more
doaj   +1 more source

SRC (v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)) [PDF]

open access: yes, 2010
Review on SRC (v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)), with data on DNA, on the protein encoded, and where the gene is ...
S Hiscox, Hiscox, S
core   +1 more source

Decoding Biomolecular Phase Separation: From Physiological Roles to Pathological Mechanisms and Therapeutic Biomaterials Design

open access: yesAdvanced Science, EarlyView.
This review systematically elaborates on the mechanisms underlying physiological regulation and pathological dysregulation of biomolecular phase separation. It also summarizes advances in phase‑separation‑targeted therapeutic strategies and the design of functional biomaterials inspired by this process.
Jiawei Zhu   +5 more
wiley   +1 more source

MPP8 Facilitates DNA DSB Repair via NHEJ to Promote Chemoresistance of TNBC Independent of Methyl‐H3K9 Binding

open access: yesAdvanced Science, EarlyView.
Chemoresistance is often linked to elevated DNA repair. MPP8 is found to promote breast cancer chemoresistance as a novel NHEJ accessory factor independent of its epigenetic functions. Through multiple protein interactions, MPP8 facilitates association of DNAPK and ligase complexes to promote DNA repair progression.
Rupa Kumari, Jia Fang
wiley   +1 more source

MYC (v-myc myelocytomatosis viral oncogene homolog (avian))

open access: yes, 2000
Review on MYC (v-myc myelocytomatosis viral oncogene homolog (avian)), with data on DNA, on the protein encoded, and where the gene is ...
Atkin, NB
core   +1 more source

Hepatic Lipid Stress Drives Metabolic Dysfunction‐Associated Steatohepatitis Progression through FTO O‐GlcNAcylation‐Induced m6A Demethylation of HRAS

open access: yesAdvanced Science, EarlyView.
Lipid stress drives O‐GlcNAcylation of the m6A demethylase FTO at Ser195, enhancing its stability and demethylase activity. This modification removes m6A from HRAS mRNA, preventing its degradation and activating PI3K/AKT signaling to promote hepatic steatosis and inflammation.
Jia‐Xin Yin   +9 more
wiley   +1 more source

A Dual‐Delivery System Designed to Overcome EV‐Mediated Ferroptosis Resistance for Efficient Solid Tumor Therapy

open access: yesAdvanced Science, EarlyView.
(A) Establishment and characterization of the osteosarcoma‐targeted dual‐delivery nanoplatform mBAP1/siENO1@LNP‐OTP for simultaneous regulation of BAP1 and ENO1 in tumor cells. (B) After intravenous administration, mBAP1/siENO1@LNP‐OTP preferentially accumulates at tumor sites through OTP‐mediated targeting.
Yechao Shen   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy